CurrentBlue Cross Blue Shield - North DakotaPolicy N/A

References I-296: Eladocagene Exuparvovec for Aromatic L-Amino Acid Decarboxylase Deficiency

Customize your policy alerts

Sign up for all Blue Cross Blue Shield - North Dakota policy alerts

Know when Blue Cross Blue Shield - North Dakota releases new policies or updates existing guidance.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Reference list concerning aromatic L-amino acid decarboxylase deficiency and eladocagene exuparvovec, including clinical, regulatory, trial, product-label, and drug-compendia sources. It does not state coverage criteria, authorization requirements, coding rules, or member restrictions.

Policy Summary

PayerBlue Cross Blue Shield - North Dakota

PolicyReferences I-296

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionUse the listed sources as informational references; this document does not state coverage or authorization requirements.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

6Total references

1FDA regulatory source

1ClinicalTrials.gov study

1Product package insert

Policy Summary

PayerBlue Cross Blue Shield - North Dakota

PolicyReferences I-296

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionUse the listed sources as informational references; this document does not state coverage or authorization requirements.

SourceLink

On This Page

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentBlue Cross Blue Shield - North DakotaPolicy N/A

References I-296: Eladocagene Exuparvovec for Aromatic L-Amino Acid Decarboxylase Deficiency

Customize your policy alerts

Sign up for all Blue Cross Blue Shield - North Dakota policy alerts

Know when Blue Cross Blue Shield - North Dakota releases new policies or updates existing guidance.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerBlue Cross Blue Shield - North Dakota

PolicyReferences I-296

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionUse the listed sources as informational references; this document does not state coverage or authorization requirements.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

6Total references

1FDA regulatory source

1ClinicalTrials.gov study

1Product package insert

Policy Summary

PayerBlue Cross Blue Shield - North Dakota

PolicyReferences I-296

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionUse the listed sources as informational references; this document does not state coverage or authorization requirements.

SourceLink

On This Page

Policy Context

This reference document concerns aromatic L-amino acid decarboxylase deficiency and eladocagene exuparvovec, including clinical reference material, FDA information, a clinical trial involving ventricular-cannula administration, the Kebilidi package insert, and drug-compendia sources. It is provided for informational reference and does not establish coverage criteria, prior-authorization requirements, coding rules, billing instructions, or member-specific restrictions.

Reference Sources

Source	Reference
GeneReviews
Blau N, Pearson TS, Kurian MA, et al. Aromatic L-Amino Acid Decarboxylase Deficiency. 2023 Oct 12. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.